Goldman Sachs’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,643
| Closed | -$8K | – | 6017 |
|
|
2022
Q1 | $8K | Sell |
1,643
-2,070
| -56% | -$10.1K | ﹤0.01% | 5698 |
|
|
2021
Q4 | $21K | Sell |
3,713
-2,287
| -38% | -$12.9K | ﹤0.01% | 5454 |
|
|
2021
Q3 | $67K | Buy |
6,000
+3,581
| +148% | +$40K | ﹤0.01% | 5134 |
|
|
2021
Q2 | $41K | Sell |
2,419
-14,378
| -86% | -$244K | ﹤0.01% | 5266 |
|
|
2021
Q1 | $441K | Buy |
16,797
+4,796
| +40% | +$126K | ﹤0.01% | 4441 |
|
|
2020
Q4 | $434K | Buy |
12,001
+10,365
| +634% | +$375K | ﹤0.01% | 3899 |
|
|
2020
Q3 | $58K | Buy |
1,636
+519
| +46% | +$18.4K | ﹤0.01% | 4309 |
|
|
2020
Q2 | $47K | Buy |
+1,117
| New | +$47K | ﹤0.01% | 4253 |
|
|
2017
Q3 | – | Sell |
-146
| Closed | -$7K | – | 4477 |
|
|
2017
Q2 | $7K | Sell |
146
-102
| -41% | -$4.89K | ﹤0.01% | 4377 |
|
|
2017
Q1 | $36K | Buy |
248
+67
| +37% | +$9.73K | ﹤0.01% | 4257 |
|
|
2016
Q4 | $18K | Sell |
181
-13
| -7% | -$1.29K | ﹤0.01% | 4368 |
|
|
2016
Q3 | $20K | Sell |
194
-20
| -9% | -$2.06K | ﹤0.01% | 4447 |
|
|
2016
Q2 | $19K | Sell |
214
-67
| -24% | -$5.95K | ﹤0.01% | 4417 |
|
|
2016
Q1 | $15K | Buy |
+281
| New | +$15K | ﹤0.01% | 4400 |
|
|
2015
Q4 | – | Sell |
-218
| Closed | -$159K | – | 4670 |
|
|
2015
Q3 | $159K | Sell |
218
-280
| -56% | -$204K | ﹤0.01% | 3965 |
|
|
2015
Q2 | $403K | Sell |
498
-133
| -21% | -$108K | ﹤0.01% | 3499 |
|
|
2015
Q1 | $466K | Buy |
631
+441
| +232% | +$326K | ﹤0.01% | 3357 |
|
|
2014
Q4 | $128K | Buy |
+190
| New | +$128K | ﹤0.01% | 4175 |
|